Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1980 1
1981 1
1982 3
1984 6
1985 2
1986 3
1987 13
1988 10
1989 6
1990 10
1991 10
1992 15
1993 19
1994 21
1995 28
1996 19
1997 30
1998 33
1999 37
2000 46
2001 54
2002 74
2003 97
2004 100
2005 138
2006 193
2007 220
2008 252
2009 273
2010 367
2011 432
2012 514
2013 624
2014 733
2015 774
2016 876
2017 911
2018 1150
2019 1375
2020 1657
2021 1959
2022 2367
2023 2370
2024 2403
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,080 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G, Yang J, Jiang Y, Xu X, Wang TD, Chen Y, Li Y, Yao L, Li D, Wang L, Shen X, Yin X, Liu W, Zhou X, Zhu B, Guo Z, Liu H, Chen X, Feng Y, Tian G, Gao X, Kario K, Cai J; STEP Study Group. Zhang W, et al. Among authors: deng y. N Engl J Med. 2021 Sep 30;385(14):1268-1279. doi: 10.1056/NEJMoa2111437. Epub 2021 Aug 30. N Engl J Med. 2021. PMID: 34491661 Clinical Trial.
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial.
Reck M, Mok TSK, Nishio M, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Lee A, Coleman S, Deng Y, Kowanetz M, Shankar G, Lin W, Socinski MA; IMpower150 Study Group. Reck M, et al. Among authors: deng y. Lancet Respir Med. 2019 May;7(5):387-401. doi: 10.1016/S2213-2600(19)30084-0. Epub 2019 Mar 25. Lancet Respir Med. 2019. PMID: 30922878 Clinical Trial.
Cryo-EM structures of human GPR34 enable the identification of selective antagonists.
Xia A, Yong X, Zhang C, Lin G, Jia G, Zhao C, Wang X, Hao Y, Wang Y, Zhou P, Yang X, Deng Y, Wu C, Chen Y, Zhu J, Tang X, Liu J, Zhang S, Zhang J, Xu Z, Hu Q, Zhao J, Yue Y, Yan W, Su Z, Wei Y, Zhou R, Dong H, Shao Z, Yang S. Xia A, et al. Among authors: deng y. Proc Natl Acad Sci U S A. 2023 Sep 26;120(39):e2308435120. doi: 10.1073/pnas.2308435120. Epub 2023 Sep 21. Proc Natl Acad Sci U S A. 2023. PMID: 37733739 Free PMC article.
Pangenome analysis reveals genomic variations associated with domestication traits in broomcorn millet.
Chen J, Liu Y, Liu M, Guo W, Wang Y, He Q, Chen W, Liao Y, Zhang W, Gao Y, Dong K, Ren R, Yang T, Zhang L, Qi M, Li Z, Zhao M, Wang H, Wang J, Qiao Z, Li H, Jiang Y, Liu G, Song X, Deng Y, Li H, Yan F, Dong Y, Li Q, Li T, Yang W, Cui J, Wang H, Zhou Y, Zhang X, Jia G, Lu P, Zhi H, Tang S, Diao X. Chen J, et al. Among authors: deng y. Nat Genet. 2023 Dec;55(12):2243-2254. doi: 10.1038/s41588-023-01571-z. Epub 2023 Nov 30. Nat Genet. 2023. PMID: 38036791 Free PMC article.
Ligand recognition and G-protein coupling of trace amine receptor TAAR1.
Xu Z, Guo L, Yu J, Shen S, Wu C, Zhang W, Zhao C, Deng Y, Tian X, Feng Y, Hou H, Su L, Wang H, Guo S, Wang H, Wang K, Chen P, Zhao J, Zhang X, Yong X, Cheng L, Liu L, Yang S, Yang F, Wang X, Yu X, Xu Y, Sun JP, Yan W, Shao Z. Xu Z, et al. Among authors: deng y. Nature. 2023 Dec;624(7992):672-681. doi: 10.1038/s41586-023-06804-z. Epub 2023 Nov 7. Nature. 2023. PMID: 37935376
18,080 results
You have reached the last available page of results. Please see the User Guide for more information.